Skip to main content
. 2020 May 7;7:139. doi: 10.3389/fmed.2020.00139

Table 2.

Prognosis factors of recurrence-free survival and overall survival in the whole patients.

Variables Recurrence-free survival Overall survival
Univariable Multivariable Univariable Multivariable
Hazard ratio (95% CI) P-value Hazard ratio (95% CI) P-value Hazard ratio (95%CI) P-value Hazard ratio (95% CI) P-value
Sex, male 1.487 (1.135, 1.948) 0.004 1.696 (1.285, 2.238) <0.001 1.171 (0.777, 1.765) 0.450
Age, year 1.000 (0.990, 1.009) 0.941 1.020 (1.005, 1.035) 0.010
TBIL, μmol/L 1.009 (0.995, 1.023) 0.197 1.014 (0.991, 1.037) 0.231
TP, g/L 0.968 (0.951, 0.984) <0.001 0.973 (0.947, 0.999) 0.043
ALB, g/L 0.926 (0.903, 0.949) <0.001 0.955 (0.929, 0.982) 0.001 0.897 (0.862, 0.932) <0.001
ALT, U/L 1.005 (1.003, 1.008) <0.001 1.001 (0.995, 1.006) 0.852
AST, U/L 1.012 (1.007, 1.016) <0.001 1.006 (1.002, 1.011) 0.010 1.009 (1.002, 1.016) 0.008
GGT, U/L 1.003 (1.002, 1.004) <0.001 1.001 (1.000, 1.002) 0.042 1.003 (1.001, 1.004) <0.001 1.002 (1.000, 1.003) 0.026
ALP, U/L 1.006 (1.002, 1.010) 0.002 1.011 (1.006, 1.017) <0.001
AFP, ng/mL 1.000 (1.000, 1.000) 0.285 1.000 (1.000, 1.001) 0.149
CA199, ng/mL 1.004 (1.000, 1.008) 0.036 1.005 (0.999, 1.011) 0.107
WBC, ×109/L 0.932 (0.879, 0.988) 0.019 0.965 (0.879, 1.060) 0.456
RBC, ×109/L 0.896 (0.744, 1.081) 0.252 0.577 (0.435, 0.765) <0.001
PLT, ×109/L 0.997 (0.995, 0.998) <0.001 0.997 (0.994, 0.999) 0.017
INR 33.181 (11.210, 98.218) <0.001 28.473 (5.268, 153.890) <0.001
PT, s 1.339 (1.224, 1.466) <0.001 1.181 (1.069, 1.304) 0.001 1.326 (1.152, 1.525) <0.001
HBsAg, positive 1.149 (0.831, 1.590) 0.401 0.638 (0.414, 0.981) 0.040
HBsAb, positive 0.928 (0.707, 1.218) 0.590 1.113 (0.739, 1.677) 0.609
HBeAg, positive 1.261 (1.036, 1.534) 0.020 1.220 (0.893, 1.666) 0.211
HBeAb, positive 0.939 (0.761, 1.159) 0.560 0.818 (0.589, 1.134) 0.228
HBcAb, positive 1.886 (0.470, 7.565) 0.371 0.444 (0.142, 1.390) 0.163
HBV DNA load, >103 IU/mL 1.336 (1.108, 1.610) 0.002 1.192 (0.886, 1.603) 0.246
Child–Pugh, B 1.912 (1.122, 3.257) 0.017 2.042 (0.904, 4.611) 0.086
Hepatectomy, anatomical 0.814 (0.620, 1.068) 0.138 0.758 (0.480, 1.195) 0.233
Transfusion, yes 1.233 (0.938, 1.622) 0.134 1.306 (0.855, 1.994) 0.217
Pringle maneuver, yes 0.996 (0.767, 1.294) 0.977 1.012 (0.668, 1.535) 0.954
Diameter, cm 1.101 (1.006, 1.204) 0.036 1.304 (1.128, 1.506) <0.001 1.279 (1.103, 1.483) 0.001
Cirrhosis, yes 1.511 (1.237, 1.845) <0.001 1.727 (1.239, 2.407) <0.001 1.529 (1.085, 2.155) 0.015
Capsule, no 1.161 (0.894, 1.507) 0.264 1.529 (1.052, 2.223) 0.026
MVI, yes 1.506 (1.249, 1.816) <0.001 1.667 (1.378, 2.017) <0.001 2.369 (1.759, 3.192) <0.001 2.578 (1.905, 3.488) <0.001
ES grade, III–IV 1.046 (0.859, 1.274) 0.654 1.754 (1.237, 2.489) 0.002
Surgical margin, narrow 1.795 (1.487, 2.168) <0.001 1.781 (1.469, 2.160) <0.001 1.924 (1.418, 2.611) <0.001 1.935 (1.413, 2.650) <0.001

TBIL, total bilirubin; TP, total protein; ALB, albumin; ALT, alanine transaminase; AST, aspartate aminotransferase; GGT, γ-glutamyl transpeptidase; ALP, alkaline phosphatase; AFP, α fetal protein; CA199, carbohydrate antigen 19-9; WBC, white blood cells; RBC, red blood cells; PLT, platelets; INR, international normalized ratio; PT, prothrombin time; HBsAg, hepatitis B surface antigen; HBsAb, hepatitis B surface antibody; HBeAg, hepatitis B e antigen; HBeAb, hepatitis B e antibody; HBcAb, hepatitis B c antibody; HBV DNA, hepatitis B virus deoxyribonucleic acid; MVI, microvascular invasion; ES, Edmondson–Steiner.